1[1]Waagstein F,Hjalmarson A,Vamauskas E,et al.Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.Br Heart J,1975,37:1022-1036
2[2]Bristow MR.Mechanism of action of betablocking agents in heart failuere.Am J Cardiol,1997,80:7-14
3[3]Feuerstein GZ,Bril A,Ruffolo RR.Proective effects of carvedilol in the myocardium.Am J Cardiol,1997,80:41-45
4[4]Waagstein F,Brisiow MR,Swedberg K,et al.Beneficial effects of metopiolol in idiopathic delated cardiomyopathy.Metoprolol in Dilated Cardiomyopathy(MDC)Trial Study Group.Lancet.1993,11:342:1441-1446
5[5]Lechat P,Packer M,Chalon S,et al.Clinical effects of β-adrenergic blokade in chronic heart failure.Circulation,1998,98:1184-1191
6[6]CIBIS Investigators and Committees.A randomized trial of β-blockade in heart failure.The cardiac insufficiency study(CIBIS).Circulation 1994,90:1765-1773
7[7]CIBIS-11 Investigators and Committees.The cardiac insufficiency bisoprolol study 11(CIBIS-11).Lancet,1999,353:9-13
8[8]Packer M,Bristow MR,Cohn JN,et al.The effect of carvedilol on morbidity and motality in patients with chronic heart failure.N Engl J Med,1996,334:1349-1355
9[9]Heidenreich PA, Lee TT,Massie BM,et al.Effect for beat-blocker on mortality in patients with heart failure:a meta-anlaysis of randomized clinical trials.J Am Coll Cardiol,1997,30:27
10[10]The international Steering Committee on bdhalf of the MERIT-HF Study Group.J Am Coll Cardiol.1997,80[Suppl]:54j-58j
